Exchange: OTC·Updated 09:30 AM EDT

ARDS Aridis Pharmaceuticals Inc

$0.0001
$0.00
(0.00%)
Today
Mkt Cap$4,457.00
Vol529.00

About ARDS

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
61

Bullish Sentiment

How do you feel about ARDS?

Advertisement|Remove ads.